CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $1.21B, above the global median of $1.15B
- FinancialsAltman Z-Score 13.8: safe zone
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.18%
Annual Rate
INR 1.00Paid annual
Payout Ratio
20.5%Sustainable
Last Ex-Dividend
May 19, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
115.50BINR1.21B · vs all stocks (USD)
Trailing P/E
55.10xvs Diagnostics & Research peers
Revenue (TTM)
17.10BINR178.68M · vs all stocks (USD)
Profit Margin
11.79%vs Diagnostics & Research peers
Beta
0.2060xvs all stocks
52-Week Change
1.86%vs all stocks
Market Capitalization
115.50BINR1.21B · vs all stocks (USD)
Enterprise Value
115.47BINR1.21B · vs all stocks (USD)
Trailing P/E
55.10xvs Diagnostics & Research peers
Forward P/E
34.77xvs Diagnostics & Research peers
PEG Ratio
2.16xPrice to Sales (TTM)
6.56xvs Diagnostics & Research peers
Price to Book (MRQ)
7.41xvs Diagnostics & Research peers
Enterprise to Revenue
6.75xvs Diagnostics & Research peers
Enterprise to EBITDA
36.15xvs Diagnostics & Research peers
Gross Margin
79.25%vs Diagnostics & Research peers
Profit Margin
11.79%vs Diagnostics & Research peers
Operating Margin
17.50%vs Diagnostics & Research peers
Return on Assets (TTM)
8.89%vs Diagnostics & Research peers
Return on Equity (TTM)
12.46%vs Diagnostics & Research peers
Revenue (TTM)
17.10BINR178.68M · vs all stocks (USD)
Revenue per Share (TTM)
85.63INRUpdated Aug 21, 2026Quarterly Revenue Growth
16.60%vs Diagnostics & Research peers
Gross Profit (TTM)
13.29BINR138.90M · vs all stocks (USD)
EBITDA (TTM)
4.44BINR46.38M · vs all stocks (USD)
Net Income (TTM)
2.02BINR21.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.80%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
3.51BINR36.64M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.90BINR19.85M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.18%vs all stocks
Payout Ratio
20.51%vs Diagnostics & Research peers
Minority Interest (Equity)
113.94MINRFY2026 · Mar 31, 2026Revenue
16.46BINRFY2026 · Mar 31, 2026Cost of Goods Sold
3.48BINRFY2026 · Mar 31, 2026Gross Profit
12.98BINRFY2026 · Mar 31, 2026Operating Income
2.67BINR27.91M · vs all stocks (USD)
Pre-tax Income
2.59BINRFY2026 · Mar 31, 2026Income Tax Expense
679.94MINRFY2026 · Mar 31, 2026Net Income
1.91BINRFY2026 · Mar 31, 2026EBIT
2.84BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
4.26BINRFY2026 · Mar 31, 2026Other Operating Expenses
5.20BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
245.44MINRFY2026 · Mar 31, 2026EPS (Basic)
9.19INRFY2026 · Mar 31, 2026EPS (Diluted)
9.19INRFY2026 · Mar 31, 2026Basic Shares Outstanding
206.77MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
206.77MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
-11.65MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
2.31BINRFY2026 · Mar 31, 2026Free Cash Flow
1.88BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
547.84MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
2.59BINRFY2026 · Mar 31, 2026Stock-based Compensation
80.74MINRFY2026 · Mar 31, 2026Other Non-cash Items
210.39MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-489.68MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-84.81MINRFY2026 · Mar 31, 2026Capital Expenditures
-432.19MINRFY2026 · Mar 31, 2026Net Intangibles (CF)
-76.95MINRFY2026 · Mar 31, 2026Net Acquisitions
-1.13BINRFY2026 · Mar 31, 2026Purchase of Investments
-4.21BINRFY2026 · Mar 31, 2026Sale of Investments
3.61BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-2.17BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
45.37MINRFY2026 · Mar 31, 2026Common Dividends Paid
-207.29MINRFY2026 · Mar 31, 2026Other Financing Charges
65.60MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-96.25MINRFY2026 · Mar 31, 2026Shares Outstanding
207.39MSharesUpdated Aug 21, 2026Float Shares
106.04MSharesUpdated Aug 21, 2026% Held by Insiders
47.84%vs all stocks
% Held by Institutions
44.60%vs all stocks
Total Cash (MRQ)
2.03BINR21.21M · vs all stocks (USD)
Total Cash per Share (MRQ)
9.79INRUpdated Aug 21, 2026Total Debt (MRQ)
2.32BINR24.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1521xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.40xvs Diagnostics & Research peers
Book Value per Share (MRQ)
72.98INRUpdated Aug 21, 2026Total Assets
21.38BINR223.41M · vs all stocks (USD)
Total Current Assets
4.69BINRFY2026 · Mar 31, 2026Total Liabilities
6.13BINRFY2026 · Mar 31, 2026Total Non-current Assets
16.69BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
2.79BINRFY2026 · Mar 31, 2026Total Current Liabilities
3.34BINRFY2026 · Mar 31, 2026Cash
341.37MINRFY2026 · Mar 31, 2026Cash Equivalents
206.46MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
547.84MINRFY2026 · Mar 31, 2026Other Short-term Investments
1.48BINRFY2026 · Mar 31, 2026Accounts Receivable
1.70BINRFY2026 · Mar 31, 2026Inventory
454.94MINRFY2026 · Mar 31, 2026Accounts Payable
1.29BINRFY2026 · Mar 31, 2026Short-term Debt
936.46MINRFY2026 · Mar 31, 2026Other Current Liabilities
270.09MINRFY2026 · Mar 31, 2026Long-term Debt
1.38BINRFY2026 · Mar 31, 2026Common Stock (Book)
414.66MINRFY2026 · Mar 31, 2026Retained Earnings
12.03BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
15.25BINR159.30M · vs all stocks (USD)
52-Week Low
412.25INRUpdated Aug 21, 202652-Week High
609.05INRUpdated Aug 21, 202652-Week Change
1.86%vs all stocks
Beta
0.2060xvs all stocks
50-Day MA
557.96INRUpdated Aug 21, 2026200-Day MA
501.27INRUpdated Aug 21, 2026Avg 10-Day Volume
225.68KSharesUpdated Aug 21, 2026Avg 30-Day Volume
256.69KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
9.82INRUpdated Aug 21, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 13.8: safe zoneNotable
Altman Z-Score: 13.80
High earnings qualityNotable
Earnings Quality Score: 1.13
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $1.21B, above the global median of $1.15BNotable
Market cap (USD): 1,206,906,604.834Global Median: 1,146,734,693.424
Levered free cash flow is $19.85M, above the global median of $16.24MNotable
Levered free cash flow (USD): 19,854,918.126Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Shinkong Synthetic Fibers Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Zynp Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Lelon Electronics Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huabao Flavours & Fragrances Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shandong Boyuan Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Qifan Cable Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hunan Corun New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Jiangsu Shagang Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Taiwan Puritic Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zbit Semiconductor Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
XPEL, Inc.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
Grindwell Norton Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin
Fabrinet
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year FCF With Growth And Margin